Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2002
03/19/2002US6358959 Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
03/19/2002US6358958 Arylpiperazines having activity at the serotonin 1A receptor
03/19/2002US6358956 Inhibitors of prenyl-protein transferase
03/19/2002US6358955 Schizophrenia, psychological disorders, parkinson*s disease; antidepressants
03/19/2002US6358945 Compounds useful as anti-inflammatory agents
03/19/2002US6358887 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
03/19/2002US6358286 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected
03/19/2002CA2173963C Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
03/19/2002CA2047347C Thioalkylthio cephalosporins derivatives
03/14/2002WO2002020513A1 Oxindole derivatives
03/14/2002WO2002020512A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
03/14/2002WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents
03/14/2002WO2002020495A2 Inhibitors of glycogen synthase kinase 3
03/14/2002WO2002020492A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
03/14/2002WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE
03/14/2002WO2002020488A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
03/14/2002WO2002020487A1 Substituted 1-aryl-pyridin-2-(thi)ones
03/14/2002WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/14/2002WO2002020484A1 Chemical compounds
03/14/2002WO2002020483A1 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors
03/14/2002WO2002020480A1 Substituted fused pyrroleimines and pyrazoleimines
03/14/2002WO2002020479A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
03/14/2002WO2002020437A2 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
03/14/2002WO2002020011A2 A method for treating allergies using substituted pyrazoles
03/14/2002WO2002019994A2 The treatment of inflammatory disorders
03/14/2002WO2002019967A2 Substituted hydrazine derivatives
03/14/2002WO2001082909A3 2-acyl indol derivatives and their use as anti-tumour agents
03/14/2002WO2001074790A3 Novel compounds for enhancing chemotherapy
03/14/2002WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
03/14/2002WO2001070692A3 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides
03/14/2002WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
03/14/2002WO2001064671A3 Haloimidazole derivatives and their use as muscarinic m3 and serotoninergic 5-ht4 receptors
03/14/2002WO2001064668A3 1,3-dihydro-2h-indol-2-one, and their use as v1b or both v1b and v1a arginine-vasopressin ligand receptors
03/14/2002WO2001062737A3 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
03/14/2002US20020032328 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
03/14/2002US20020032325 4-amino-3-mercapto-1,2,4-triazoles
03/14/2002US20020032223 Benzamidine derivatives and their use as anti-coagulants
03/14/2002US20020032221 Treatment of HIV mediated diseases.
03/14/2002US20020032219 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
03/14/2002US20020032210 Chloride channel blockers; useful in the treatment of sickle cell anaemia, brain edema following iscaemia or tumors, diarrhea, hypertension, bone metabolic disorders, osteoclast associated disoders; substituted biphenyl containing nitrogen
03/14/2002US20020032208 Chemical compounds
03/14/2002US20020032204 Reacting a substituted indol-2-one compound with an acyclic or cyclic amine free of piperidine-1-yl or morpholine-4-yl to form protein kinase inhibitor
03/14/2002US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
03/14/2002US20020032199 5-HT7 receptor antagonists
03/14/2002US20020032198 Diaminopyrazoles
03/14/2002US20020032195 An mono or polycyclic aromatic or heteroaromatic carbamate or urea or thiacarbamoyl derivatives; inhibit production of cytokines involved in inflammatory processes
03/14/2002US20020032191 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
03/14/2002US20020032184 For therapy of human immunodeficiency viral (HIV) , or genetically related retroviral, infection or a resulting acquired immunodeficiency syndrome (AIDS)
03/14/2002US20020032183 Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as JNK-inhibitors
03/14/2002US20020032174 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
03/14/2002DE10065434A1 Indole Indoles
03/14/2002DE10043790A1 Substituierte 1-Aryl-pyridin-2-(thi)one Substituted 1-aryl-pyridin-2- (thi) ones
03/14/2002DE10042655A1 Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion Process for the preparation of inhibitors of cell adhesion
03/14/2002DE10041402A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity
03/14/2002DE10023486C1 Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel Ortho-substituted anthranilic acid amides and their use as medicaments
03/14/2002CA2422198A1 Substituted hydrazine derivatives
03/14/2002CA2421493A1 A method for treating allergies using substituted pyrazoles
03/14/2002CA2420703A1 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
03/14/2002CA2419966A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
03/14/2002CA2419958A1 Substituted fused pyrroleimines and pyrazoleimines
03/14/2002CA2419601A1 The treatment of inflammatory disorders
03/14/2002CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/13/2002EP1186603A2 Processes for preparing endothelin antagonists
03/13/2002EP1186602A2 Omeprazole sodium salt and its use as anti-ulcer agent
03/13/2002EP1186601A1 Novel isoquinoline derivatives or salts thereof
03/13/2002EP1186597A1 Process for the production of 2-pyridylpyridine derivatives
03/13/2002EP1186596A1 Process for the production of 2-pyridylpyridine derivatives
03/13/2002EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist
03/13/2002EP1185528A1 Inhibitors of il-12 production
03/13/2002EP1185525A1 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
03/13/2002EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors
03/13/2002EP1185512A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185511A2 Inhibitors of factor xa
03/13/2002EP1185509A2 INHIBITORS OF FACTOR Xa
03/13/2002EP1185508A2 Inhibitors of factor xa
03/13/2002EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
03/13/2002EP1185267A1 Dermal anesthetic agents
03/13/2002EP0975219B1 Fungicide active substance combinations
03/13/2002EP0948483B1 Farnesyl transferase inhibitors
03/13/2002EP0802910B1 Estrogen agonists/antagonists
03/13/2002CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4
03/13/2002CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents
03/13/2002CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists
03/13/2002CN1340045A 5-HTIF agonists
03/13/2002CN1340044A Nervinolin derivatives
03/13/2002CN1080721C 1-(5-isoquinolinesulfonyl)homopiperazine hydrochloride hydrate
03/12/2002US6355810 Multibinding inhibitors of HMG-CoA reductase
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355803 Compound comprising extended, coplanar, conjugated system, formed by attachment of functional group comprising aromatic ring and electron-donating group on acridinium nucleus, which maintains coplanarity during light emission
03/12/2002US6355799 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
03/12/2002US6355695 Antihistamines; asthma therapy
03/12/2002US6355673 Substituted diaminocarboxylic acids
03/12/2002US6355664 Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
03/12/2002US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents
03/12/2002US6355660 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
03/12/2002US6355659 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
03/12/2002US6355642 Tetrahydrobenzindole compounds
03/12/2002US6355635 Imidazolebenzene, imidazolepyridine compounds for treatment of obesity
03/12/2002US6355631 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
03/12/2002US6355460 Detecting enzyme inhibitors; incubate enzyme with modulator, monitor sample for reduction in enzyme activity, reduction in enzyme activity indicates modulator